Skip to content
Disclosery

EXANE DERIVATIVES: PGR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on PGR, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 4,219 PGR shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 4,219 shares
    Change vs previous 13F -4,423 shares

    0.28% of the 13F portfolio, value $490,443.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 8,642 shares
    Change vs previous 13F +1,746 shares

    0.28% of the 13F portfolio, value $985,041.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 6,896 shares
    Change vs previous 13F +170 shares

    0.17% of the 13F portfolio, value $707,849.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 6,726 shares
    Change vs previous 13F +966 shares

    0.15% of the 13F portfolio, value $607,941.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 5,760 shares
    Change vs previous 13F +274 shares

    0.13% of the 13F portfolio, value $563,258.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 5,486 shares
    Change vs previous 13F -21 shares

    0.16% of the 13F portfolio, value $524,493.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 5,507 shares
    Change vs previous 13F +5,478 shares

    0.17% of the 13F portfolio, value $544,507.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 29 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $2,745.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).